메뉴 건너뛰기




Volumn 361, Issue 1, 2015, Pages 86-96

Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells

Author keywords

Biomarkers; Cancer stem cells; Metastatic microenvironment; Vemurafenib resistance

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD271 ANTIGEN; CELL MARKER; FIBRONECTIN; GELATINASE A; INTERSTITIAL COLLAGENASE; JARID1B PROTEIN; MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG; VEMURAFENIB; INDOLE DERIVATIVE; MESSENGER RNA; SULFONAMIDE; TUMOR MARKER;

EID: 84925168341     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.02.041     Document Type: Article
Times cited : (46)

References (69)
  • 1
    • 0034762203 scopus 로고    scopus 로고
    • The Raf/MEK/ERK pathway: new concepts of activation
    • Peyssonnaux C., Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell 2001, 93(1-2):53-62.
    • (2001) Biol. Cell , vol.93 , Issue.1-2 , pp. 53-62
    • Peyssonnaux, C.1    Eychene, A.2
  • 2
    • 18444374405 scopus 로고    scopus 로고
    • Mutations of the BRAF gene in human cancer
    • Davies H., et al. Mutations of the BRAF gene in human cancer. Nature 2002, 417(6892):949-954.
    • (2002) Nature , vol.417 , Issue.6892 , pp. 949-954
    • Davies, H.1
  • 3
    • 79959795786 scopus 로고    scopus 로고
    • Improved survival with vemurafenib in melanoma with BRAF V600E mutation
    • Chapman P.B., et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med 2011, 364(26):2507-2516.
    • (2011) N. Engl. J. Med , vol.364 , Issue.26 , pp. 2507-2516
    • Chapman, P.B.1
  • 4
    • 84875706825 scopus 로고    scopus 로고
    • Resistance to BRAF-targeted therapy in melanoma
    • Sullivan R.J., Flaherty K.T. Resistance to BRAF-targeted therapy in melanoma. Eur. J. Cancer 2013, 49(6):1297-1304.
    • (2013) Eur. J. Cancer , vol.49 , Issue.6 , pp. 1297-1304
    • Sullivan, R.J.1    Flaherty, K.T.2
  • 5
    • 84904888606 scopus 로고    scopus 로고
    • Systemic treatment for BRAF-mutant melanoma: where do we go next?
    • Menzies A.M., Long G.V. Systemic treatment for BRAF-mutant melanoma: where do we go next?. Lancet Oncol 2014, 15(9):e371-e381.
    • (2014) Lancet Oncol , vol.15 , Issue.9 , pp. e371-e381
    • Menzies, A.M.1    Long, G.V.2
  • 6
    • 84902008991 scopus 로고    scopus 로고
    • The multiple facets of drug resistance: one history, different approaches
    • Niero E.L., et al. The multiple facets of drug resistance: one history, different approaches. J. Exp. Clin. Cancer Res 2014, 33:37.
    • (2014) J. Exp. Clin. Cancer Res , vol.33 , pp. 37
    • Niero, E.L.1
  • 7
    • 84905845186 scopus 로고    scopus 로고
    • Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
    • Panczyk M. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World J. Gastroenterol 2014, 20(29):9775-9827.
    • (2014) World J. Gastroenterol , vol.20 , Issue.29 , pp. 9775-9827
    • Panczyk, M.1
  • 8
    • 0021916585 scopus 로고
    • Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance
    • Bell D.R., et al. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J. Clin. Oncol 1985, 3(3):311-315.
    • (1985) J. Clin. Oncol , vol.3 , Issue.3 , pp. 311-315
    • Bell, D.R.1
  • 9
    • 56449108015 scopus 로고    scopus 로고
    • Role of microRNAs in drug-resistant ovarian cancer cells
    • Sorrentino A., et al. Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol. Oncol 2008, 111(3):478-486.
    • (2008) Gynecol. Oncol , vol.111 , Issue.3 , pp. 478-486
    • Sorrentino, A.1
  • 10
    • 84903544283 scopus 로고    scopus 로고
    • VAV3 mediates resistance to breast cancer endocrine therapy
    • Aguilar H., et al. VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res 2014, 16(3):R53.
    • (2014) Breast Cancer Res , vol.16 , Issue.3 , pp. R53
    • Aguilar, H.1
  • 11
    • 84863221252 scopus 로고    scopus 로고
    • The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis
    • Izraely S., et al. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis. Int. J. Cancer 2012, 131(5):1071-1082.
    • (2012) Int. J. Cancer , vol.131 , Issue.5 , pp. 1071-1082
    • Izraely, S.1
  • 12
    • 84922242833 scopus 로고    scopus 로고
    • The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis
    • Izraely S., Sagi-Assif O., Klein A., Meshel T., Ben-Menachem S., Zaritsky A., et al. The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis. Int. J. Cancer 2015, 15:1296-1307.
    • (2015) Int. J. Cancer , vol.15 , pp. 1296-1307
    • Izraely, S.1    Sagi-Assif, O.2    Klein, A.3    Meshel, T.4    Ben-Menachem, S.5    Zaritsky, A.6
  • 13
    • 27744460321 scopus 로고    scopus 로고
    • Blood-brain barrier-specific properties of a human adult brain endothelial cell line
    • Weksler B.B., et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 2005, 19(13):1872-1874.
    • (2005) FASEB J. , vol.19 , Issue.13 , pp. 1872-1874
    • Weksler, B.B.1
  • 14
    • 0036433641 scopus 로고    scopus 로고
    • In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R
    • Unger R.E., et al. In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc. Res 2002, 64(3):384-397.
    • (2002) Microvasc. Res , vol.64 , Issue.3 , pp. 384-397
    • Unger, R.E.1
  • 15
    • 84885672794 scopus 로고    scopus 로고
    • Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS
    • Duan H., et al. Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS. Sci. Rep 2013, 3:1687.
    • (2013) Sci. Rep , vol.3 , pp. 1687
    • Duan, H.1
  • 16
    • 0032528352 scopus 로고    scopus 로고
    • Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells
    • Yamamoto H., Sedgwick J.B., Busse W.W. Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J. Immunol 1998, 161(2):971-977.
    • (1998) J. Immunol , vol.161 , Issue.2 , pp. 971-977
    • Yamamoto, H.1    Sedgwick, J.B.2    Busse, W.W.3
  • 17
    • 0035833247 scopus 로고    scopus 로고
    • RhoA is required for monocyte tail retraction during transendothelial migration
    • Worthylake R.A., et al. RhoA is required for monocyte tail retraction during transendothelial migration. J. Cell Biol 2001, 154(1):147-160.
    • (2001) J. Cell Biol , vol.154 , Issue.1 , pp. 147-160
    • Worthylake, R.A.1
  • 18
    • 17644386200 scopus 로고    scopus 로고
    • High-throughput microtiter assay for Hoechst 33342 dye uptake
    • Seigel G.M., Campbell L.M. High-throughput microtiter assay for Hoechst 33342 dye uptake. Cytotechnology 2004, 45(3):155-160.
    • (2004) Cytotechnology , vol.45 , Issue.3 , pp. 155-160
    • Seigel, G.M.1    Campbell, L.M.2
  • 19
    • 0142121516 scopus 로고    scopus 로고
    • Exploration, normalization, and summaries of high density oligonucleotide array probe level data
    • Irizarry R.A., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264.
    • (2003) Biostatistics , vol.4 , Issue.2 , pp. 249-264
    • Irizarry, R.A.1
  • 20
    • 84884308857 scopus 로고    scopus 로고
    • The role of tumor necrosis factor-alpha and interferon-gamma in regulating angiomotin-like protein 1 expression in lung microvascular endothelial cells
    • Nakajima Y., Nakamura Y., Shigeeda W., Tomoyasu M., Deguchi H., Tanita T., et al. The role of tumor necrosis factor-alpha and interferon-gamma in regulating angiomotin-like protein 1 expression in lung microvascular endothelial cells. Allergol. Int 2013, 62(3):309-322.
    • (2013) Allergol. Int , vol.62 , Issue.3 , pp. 309-322
    • Nakajima, Y.1    Nakamura, Y.2    Shigeeda, W.3    Tomoyasu, M.4    Deguchi, H.5    Tanita, T.6
  • 21
    • 57649240411 scopus 로고    scopus 로고
    • Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop
    • Willmarth N.E., Baillo A., Dziubinski M.L., Wilson K., Riese D.J., Ethier S.P. Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop. Cell. Signal 2009, 21(2):212-219.
    • (2009) Cell. Signal , vol.21 , Issue.2 , pp. 212-219
    • Willmarth, N.E.1    Baillo, A.2    Dziubinski, M.L.3    Wilson, K.4    Riese, D.J.5    Ethier, S.P.6
  • 22
    • 84927630294 scopus 로고    scopus 로고
    • Transcriptional regulation of CCL20 expression
    • Zhao L., Xia J., Wang X., Xu F. Transcriptional regulation of CCL20 expression. Microbes Infect 2014, 16:864-870.
    • (2014) Microbes Infect , vol.16 , pp. 864-870
    • Zhao, L.1    Xia, J.2    Wang, X.3    Xu, F.4
  • 23
    • 84907393776 scopus 로고    scopus 로고
    • E-cadherin and gastric cancer: cause, consequence, and applications
    • Liu X., Chu K.M. E-cadherin and gastric cancer: cause, consequence, and applications. Biomed Res. Int 2014, 2014:637308.
    • (2014) Biomed Res. Int , vol.2014 , pp. 637308
    • Liu, X.1    Chu, K.M.2
  • 25
    • 84904684249 scopus 로고    scopus 로고
    • Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas
    • Liu B., Pang B., Hou X., Fan H., Liang N., Zheng S., et al. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas. Hum. Pathol 2014, 45(8):1752-1758.
    • (2014) Hum. Pathol , vol.45 , Issue.8 , pp. 1752-1758
    • Liu, B.1    Pang, B.2    Hou, X.3    Fan, H.4    Liang, N.5    Zheng, S.6
  • 26
    • 84904270593 scopus 로고    scopus 로고
    • Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer
    • Kong D., Su G., Zha L., Zhang H., Xiang J., Xu W., et al. Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer. Med. Oncol 2014, 31(8):130.
    • (2014) Med. Oncol , vol.31 , Issue.8 , pp. 130
    • Kong, D.1    Su, G.2    Zha, L.3    Zhang, H.4    Xiang, J.5    Xu, W.6
  • 27
    • 33645957321 scopus 로고    scopus 로고
    • Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions
    • Apte R.N., Krelin Y., Song X., Dotan S., Recih E., Elkabets M., et al. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur. J. Cancer 2006, 42(6):751-759.
    • (2006) Eur. J. Cancer , vol.42 , Issue.6 , pp. 751-759
    • Apte, R.N.1    Krelin, Y.2    Song, X.3    Dotan, S.4    Recih, E.5    Elkabets, M.6
  • 28
    • 84897945579 scopus 로고    scopus 로고
    • The role IL-1 in tumor-mediated angiogenesis
    • Voronov E., Carmi Y., Apte R.N. The role IL-1 in tumor-mediated angiogenesis. Front. Physiol 2014, 5:114.
    • (2014) Front. Physiol , vol.5 , pp. 114
    • Voronov, E.1    Carmi, Y.2    Apte, R.N.3
  • 29
    • 77956568079 scopus 로고    scopus 로고
    • Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens
    • Kholmanskikh O., van Baren N., Brasseur F., Ottaviani S., Vanacker J., Arts N., et al. Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens. Int. J. Cancer 2010, 127(7):1625-1636.
    • (2010) Int. J. Cancer , vol.127 , Issue.7 , pp. 1625-1636
    • Kholmanskikh, O.1    van Baren, N.2    Brasseur, F.3    Ottaviani, S.4    Vanacker, J.5    Arts, N.6
  • 30
    • 84883889867 scopus 로고    scopus 로고
    • The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma
    • Chen S.F., Nieh S., Jao S.W., Wu M.Z., Liu C.L., Chang Y.C., et al. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma. J. Pathol 2013, 231(2):180-189.
    • (2013) J. Pathol , vol.231 , Issue.2 , pp. 180-189
    • Chen, S.F.1    Nieh, S.2    Jao, S.W.3    Wu, M.Z.4    Liu, C.L.5    Chang, Y.C.6
  • 31
    • 79955460636 scopus 로고    scopus 로고
    • Notch signalling in solid tumours: a little bit of everything but not all the time
    • Ranganathan P., Weaver K.L., Capobianco A.J. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat. Rev. Cancer 2011, 11(5):338-351.
    • (2011) Nat. Rev. Cancer , vol.11 , Issue.5 , pp. 338-351
    • Ranganathan, P.1    Weaver, K.L.2    Capobianco, A.J.3
  • 32
    • 77954729225 scopus 로고    scopus 로고
    • A role for the JARID1B stem cell marker for continuous melanoma growth
    • Held M., Bosenberg M. A role for the JARID1B stem cell marker for continuous melanoma growth. Pigment Cell Melanoma Res 2010, 23(4):481-483.
    • (2010) Pigment Cell Melanoma Res , vol.23 , Issue.4 , pp. 481-483
    • Held, M.1    Bosenberg, M.2
  • 33
    • 84906904987 scopus 로고    scopus 로고
    • Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming
    • Chen G., Xu X., Zhang L., Fu Y., Wang M., Gu H., et al. Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming. Cell Res 2014, 24(9):1121-1136.
    • (2014) Cell Res , vol.24 , Issue.9 , pp. 1121-1136
    • Chen, G.1    Xu, X.2    Zhang, L.3    Fu, Y.4    Wang, M.5    Gu, H.6
  • 35
    • 84905472298 scopus 로고    scopus 로고
    • MiRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells
    • Jin M., Zhang T., Liu C., Badeaux M.A., Liu B., Liu R., et al. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res 2014, 74(15):4183-4195.
    • (2014) Cancer Res , vol.74 , Issue.15 , pp. 4183-4195
    • Jin, M.1    Zhang, T.2    Liu, C.3    Badeaux, M.A.4    Liu, B.5    Liu, R.6
  • 36
    • 84893648608 scopus 로고    scopus 로고
    • The anti-miR21 antagomir, a therapeutic tool for colorectal cancer, has a potential synergistic effect by perturbing an angiogenesis-associated miR30
    • Song M.S., Rossi J.J. The anti-miR21 antagomir, a therapeutic tool for colorectal cancer, has a potential synergistic effect by perturbing an angiogenesis-associated miR30. Front. Genet 2014, 4:301.
    • (2014) Front. Genet , vol.4 , pp. 301
    • Song, M.S.1    Rossi, J.J.2
  • 37
    • 83455236760 scopus 로고    scopus 로고
    • MiR221/222 in cancer: their role in tumor progression and response to therapy
    • Garofalo M., Quintavalle C., Romano G., Croce C.M., Condorelli G. miR221/222 in cancer: their role in tumor progression and response to therapy. Curr. Mol. Med 2012, 12(1):27-33.
    • (2012) Curr. Mol. Med , vol.12 , Issue.1 , pp. 27-33
    • Garofalo, M.1    Quintavalle, C.2    Romano, G.3    Croce, C.M.4    Condorelli, G.5
  • 38
    • 78650842745 scopus 로고    scopus 로고
    • MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer
    • Chen Y., Zaman M.S., Deng G., Majid S., Saini S., Liu J., et al. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev. Res 2011, 4(1):76-86.
    • (2011) Cancer Prev. Res , vol.4 , Issue.1 , pp. 76-86
    • Chen, Y.1    Zaman, M.S.2    Deng, G.3    Majid, S.4    Saini, S.5    Liu, J.6
  • 39
    • 84902916467 scopus 로고    scopus 로고
    • Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer
    • Cierna Z., Mego M., Janega P., Karaba M., Minarik G., Benca J., et al. Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer. BMC Cancer 2014, 14:472.
    • (2014) BMC Cancer , vol.14 , pp. 472
    • Cierna, Z.1    Mego, M.2    Janega, P.3    Karaba, M.4    Minarik, G.5    Benca, J.6
  • 40
    • 71349087406 scopus 로고    scopus 로고
    • A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis
    • Blackburn J.S., Liu I., Coon C.I., Brinckerhoff C.E. A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis. Oncogene 2009, 28(48):4237-4248.
    • (2009) Oncogene , vol.28 , Issue.48 , pp. 4237-4248
    • Blackburn, J.S.1    Liu, I.2    Coon, C.I.3    Brinckerhoff, C.E.4
  • 41
    • 84927796903 scopus 로고    scopus 로고
    • Molecular regulation of ovarian cancer cell invasion
    • Sun N., Zhang Q., Xu C., Zhao Q., Ma Y., Lu X., et al. Molecular regulation of ovarian cancer cell invasion. Tumour Biol 2014, 35:11359-11366.
    • (2014) Tumour Biol , vol.35 , pp. 11359-11366
    • Sun, N.1    Zhang, Q.2    Xu, C.3    Zhao, Q.4    Ma, Y.5    Lu, X.6
  • 43
    • 84898805795 scopus 로고    scopus 로고
    • Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer
    • Wang C., Wang L., Su B., Lu N., Song J., Yang X., et al. Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer. Prostate 2014, 74(7):689-701.
    • (2014) Prostate , vol.74 , Issue.7 , pp. 689-701
    • Wang, C.1    Wang, L.2    Su, B.3    Lu, N.4    Song, J.5    Yang, X.6
  • 44
    • 77950942116 scopus 로고    scopus 로고
    • Chemokine-chemokine receptor axes in melanoma brain metastasis
    • Izraely S., et al. Chemokine-chemokine receptor axes in melanoma brain metastasis. Immunol. Lett 2010, 130(1-2):107-114.
    • (2010) Immunol. Lett , vol.130 , Issue.1-2 , pp. 107-114
    • Izraely, S.1
  • 45
    • 84867093457 scopus 로고    scopus 로고
    • The metastatic microenvironment: brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells
    • Klein A., et al. The metastatic microenvironment: brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells. Int. J. Cancer 2012, 131(11):2509-2518.
    • (2012) Int. J. Cancer , vol.131 , Issue.11 , pp. 2509-2518
    • Klein, A.1
  • 46
    • 70350683363 scopus 로고    scopus 로고
    • The tumor microenvironment: the making of a paradigm
    • Witz I.P. The tumor microenvironment: the making of a paradigm. Cancer Microenviron 2009, 2(Suppl. 1):9-17.
    • (2009) Cancer Microenviron , vol.2 , pp. 9-17
    • Witz, I.P.1
  • 47
    • 84858961972 scopus 로고    scopus 로고
    • Premetastatic niche: ready for new therapeutic interventions?
    • Zoccoli A., et al. Premetastatic niche: ready for new therapeutic interventions?. Expert Opin. Ther. Targets 2012, 16(Suppl. 2):S119-S129.
    • (2012) Expert Opin. Ther. Targets , vol.16 , pp. S119-S129
    • Zoccoli, A.1
  • 48
    • 45549093647 scopus 로고    scopus 로고
    • Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis
    • Eyler C.E., Rich J.N. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J. Clin. Oncol 2008, 26(17):2839-2845.
    • (2008) J. Clin. Oncol , vol.26 , Issue.17 , pp. 2839-2845
    • Eyler, C.E.1    Rich, J.N.2
  • 49
    • 0036154828 scopus 로고    scopus 로고
    • The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells
    • Kim M., Turnquist H., Jackson J., Sgagias M., Yan Y., Gong M., et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin. Cancer Res 2002, 8(1):22-28.
    • (2002) Clin. Cancer Res , vol.8 , Issue.1 , pp. 22-28
    • Kim, M.1    Turnquist, H.2    Jackson, J.3    Sgagias, M.4    Yan, Y.5    Gong, M.6
  • 50
    • 84871880164 scopus 로고    scopus 로고
    • Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization
    • Tirino V., et al. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J. 2013, 27(1):13-24.
    • (2013) FASEB J. , vol.27 , Issue.1 , pp. 13-24
    • Tirino, V.1
  • 51
    • 84923248130 scopus 로고    scopus 로고
    • A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms
    • Cojoc M., Mäbert K., Muders M.H., Dubrovska A. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin. Cancer Biol 2015, 31C:16-27.
    • (2015) Semin. Cancer Biol , vol.31 C , pp. 16-27
    • Cojoc, M.1    Mäbert, K.2    Muders, M.H.3    Dubrovska, A.4
  • 52
    • 84901853867 scopus 로고    scopus 로고
    • Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance
    • Easwaran H., Tsai H.C., Baylin S.B. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol. Cell 2014, 54(5):716-727.
    • (2014) Mol. Cell , vol.54 , Issue.5 , pp. 716-727
    • Easwaran, H.1    Tsai, H.C.2    Baylin, S.B.3
  • 53
    • 31844444140 scopus 로고    scopus 로고
    • The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research
    • Gottesman M.M., Ling V. The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 2006, 580(4):998-1009.
    • (2006) FEBS Lett , vol.580 , Issue.4 , pp. 998-1009
    • Gottesman, M.M.1    Ling, V.2
  • 54
    • 84893570326 scopus 로고    scopus 로고
    • Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics
    • Noguchi K., Katayama K., Sugimoto Y. Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics. Pharmgenomics. Pers. Med 2014, 7:53-64.
    • (2014) Pharmgenomics. Pers. Med , vol.7 , pp. 53-64
    • Noguchi, K.1    Katayama, K.2    Sugimoto, Y.3
  • 56
    • 84904730938 scopus 로고    scopus 로고
    • Nanodrug delivery in reversing multidrug resistance in cancer cells
    • Kapse-Mistry S., et al. Nanodrug delivery in reversing multidrug resistance in cancer cells. Front. Pharmacol 2014, 5:159.
    • (2014) Front. Pharmacol , vol.5 , pp. 159
    • Kapse-Mistry, S.1
  • 57
    • 84888200154 scopus 로고    scopus 로고
    • Nanomedicine therapeutic approaches to overcome cancer drug resistance
    • Markman J.L., et al. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv. Drug Deliv. Rev 2013, 65(13-14):1866-1879.
    • (2013) Adv. Drug Deliv. Rev , vol.65 , Issue.13-14 , pp. 1866-1879
    • Markman, J.L.1
  • 58
    • 84888205791 scopus 로고    scopus 로고
    • Rationally designed nanovehicles to overcome cancer chemoresistance
    • Livney Y.D., Assaraf Y.G. Rationally designed nanovehicles to overcome cancer chemoresistance. Adv. Drug Deliv. Rev 2013, 65(13-14):1716-1730.
    • (2013) Adv. Drug Deliv. Rev , vol.65 , Issue.13-14 , pp. 1716-1730
    • Livney, Y.D.1    Assaraf, Y.G.2
  • 59
    • 84888201303 scopus 로고    scopus 로고
    • Role of integrated cancer nanomedicine in overcoming drug resistance
    • Iyer A.K., et al. Role of integrated cancer nanomedicine in overcoming drug resistance. Adv. Drug Deliv. Rev 2013, 65(13-14):1784-1802.
    • (2013) Adv. Drug Deliv. Rev , vol.65 , Issue.13-14 , pp. 1784-1802
    • Iyer, A.K.1
  • 60
    • 84906058912 scopus 로고    scopus 로고
    • The role played by the microenvironment in site-specific metastasis
    • Klein-Goldberg A., Maman S., Witz I.P. The role played by the microenvironment in site-specific metastasis. Cancer Lett 2014, 352(1):54-58.
    • (2014) Cancer Lett , vol.352 , Issue.1 , pp. 54-58
    • Klein-Goldberg, A.1    Maman, S.2    Witz, I.P.3
  • 61
    • 46449130084 scopus 로고    scopus 로고
    • Tumor-microenvironment interactions: dangerous liaisons
    • Witz I.P. Tumor-microenvironment interactions: dangerous liaisons. Adv. Cancer Res 2008, 100:203-229.
    • (2008) Adv. Cancer Res , vol.100 , pp. 203-229
    • Witz, I.P.1
  • 62
    • 84890290450 scopus 로고    scopus 로고
    • New drug targets in metastatic melanoma
    • Homet B., Ribas A. New drug targets in metastatic melanoma. J. Pathol 2014, 232(2):134-141.
    • (2014) J. Pathol , vol.232 , Issue.2 , pp. 134-141
    • Homet, B.1    Ribas, A.2
  • 63
    • 84920486555 scopus 로고    scopus 로고
    • Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response
    • Lee C.I., et al. Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response. Breast 2015, 24(1):3-11.
    • (2015) Breast , vol.24 , Issue.1 , pp. 3-11
    • Lee, C.I.1
  • 64
    • 84908216664 scopus 로고    scopus 로고
    • Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential
    • Peddi P.F., Hurvitz S.A. Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential. Ther. Adv. Med. Oncol 2014, 6(5):202-209.
    • (2014) Ther. Adv. Med. Oncol , vol.6 , Issue.5 , pp. 202-209
    • Peddi, P.F.1    Hurvitz, S.A.2
  • 65
    • 84879603956 scopus 로고    scopus 로고
    • Metastasis: new insights into organ-specific extravasation and metastatic niches
    • Irmisch A., Huelsken J. Metastasis: new insights into organ-specific extravasation and metastatic niches. Exp. Cell Res 2013, 319(11):1604-1610.
    • (2013) Exp. Cell Res , vol.319 , Issue.11 , pp. 1604-1610
    • Irmisch, A.1    Huelsken, J.2
  • 66
    • 82255161187 scopus 로고    scopus 로고
    • Cross-talk between tumor cells and the microenvironment at the metastatic niche
    • Carlini M.J., De Lorenzo M.S., Puricelli L. Cross-talk between tumor cells and the microenvironment at the metastatic niche. Curr. Pharm. Biotechnol 2011, 12(11):1900-1908.
    • (2011) Curr. Pharm. Biotechnol , vol.12 , Issue.11 , pp. 1900-1908
    • Carlini, M.J.1    De Lorenzo, M.S.2    Puricelli, L.3
  • 67
    • 44349100383 scopus 로고    scopus 로고
    • Organ selectivity in metastasis: regulation by chemokines and their receptors
    • Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin. Exp. Metastasis 2008, 25(4):345-356.
    • (2008) Clin. Exp. Metastasis , vol.25 , Issue.4 , pp. 345-356
    • Ben-Baruch, A.1
  • 68
    • 44449114208 scopus 로고    scopus 로고
    • Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis
    • Gout S., Tremblay P.L., Huot J. Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin. Exp. Metastasis 2008, 25(4):335-344.
    • (2008) Clin. Exp. Metastasis , vol.25 , Issue.4 , pp. 335-344
    • Gout, S.1    Tremblay, P.L.2    Huot, J.3
  • 69
    • 36148967681 scopus 로고    scopus 로고
    • Metastasis: the seed and soil theory gains identity
    • Fokas E., et al. Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev 2007, 26(3-4):705-715.
    • (2007) Cancer Metastasis Rev , vol.26 , Issue.3-4 , pp. 705-715
    • Fokas, E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.